Risk Of Stroke By Atrial Fibrillation clinical trials

Explore recruiting risk of stroke by atrial fibrillation clinical trials.

Also recruiting in Europe

Risk Of Stroke By Atrial Fibrillation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Germany, Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Risk Of Stroke By Atrial Fibrillation trials by city

Risk Of Stroke By Atrial Fibrillation in Toronto Risk Of Stroke By Atrial Fibrillation in Vancouver Risk Of Stroke By Atrial Fibrillation in Montreal Risk Of Stroke By Atrial Fibrillation in Calgary Risk Of Stroke By Atrial Fibrillation in Edmonton Risk Of Stroke By Atrial Fibrillation in Ottawa Risk Of Stroke By Atrial Fibrillation in Winnipeg Risk Of Stroke By Atrial Fibrillation in Quebec City Risk Of Stroke By Atrial Fibrillation in Hamilton Risk Of Stroke By Atrial Fibrillation in Kitchener Risk Of Stroke By Atrial Fibrillation in London Risk Of Stroke By Atrial Fibrillation in Halifax Risk Of Stroke By Atrial Fibrillation in New York Risk Of Stroke By Atrial Fibrillation in Los Angeles Risk Of Stroke By Atrial Fibrillation in Chicago Risk Of Stroke By Atrial Fibrillation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease